MDBH MDB CAPITAL HOLDINGS LLC

PatentVest Highlights New Legal Article on AI Patenting Strategy by Senior Patent Attorney Sarah Cork

PatentVest Highlights New Legal Article on AI Patenting Strategy by Senior Patent Attorney Sarah Cork

Dallas, TX, March 30, 2026 (GLOBE NEWSWIRE) -- PatentVest today announced a new addition to its IP Legal Insights section on the company website, a platform dedicated to sharing expert legal perspectives on intellectual property strategy, emerging technology, and innovation-driven industries.

The IP Legal Insights section serves as a resource for founders, executives, and investors seeking to better understand how intellectual property decisions impact innovation, competitive positioning, and long-term business value. Through this platform, PatentVest’s legal and technical experts provide analysis on key patent law developments, practical prosecution strategies, and emerging trends shaping industries such as biotechnology, healthcare, and artificial intelligence.

The latest article, “Using AI in Your Inventive Process? Proceed to Patent, But Carefully,” written by Sarah Cork, Ph.D., Senior Patent Attorney at PatentVest, explores how companies can navigate the evolving legal landscape surrounding AI-assisted inventions. The article examines key considerations such as patent eligibility under Section 101, inventorship challenges, and strategic approaches to prosecution.

As the use of artificial intelligence continues to expand across industries such as biotech and healthcare, companies face increasing complexity in protecting AI-driven innovations. The article highlights how patentability often depends on claiming strategy, including demonstrating technological improvements, practical applications, and clear human contribution to the inventive process. It also addresses recent USPTO guidance and policy developments that shape how these inventions are evaluated.

“Through our IP Legal Insights section, we aim to provide actionable guidance on the most pressing legal and strategic issues facing innovators today,” said Javier Chamorro, COO at PatentVest. “As AI becomes a central component of innovation, understanding how to properly protect these advancements is critical for long-term success.”

Read the article here: . 

About PatentVest

PatentVest is an integrated intellectual property intelligence, strategy consulting, and law firm dedicated to helping visionary companies build and protect transformative technologies. By combining strategic insights with legal expertise, PatentVest enables innovators to strengthen their competitive advantage and accelerate technology leadership.

For more information or inquiries, please contact  .



EN
30/03/2026

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MDB CAPITAL HOLDINGS LLC

 PRESS RELEASE

MDB Capital Holdings Provides 2025 Full Year Update and Shareholder Le...

MDB Capital Holdings Provides 2025 Full Year Update and Shareholder Letter Management to Host Conference Call Today at 4:30 p.m. ET Addison, TX, March 31, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-defining disruptive technology companies, today reported financial and operational results for the fourth quarter and full year ended December 31, 2025. More Detailed Information 2025 Annual Shareholder Letter . Form 10-K . Key Assets and Strategic Developments eXoZymes (NASDAQ: EXOZ): MDB holds appr...

 PRESS RELEASE

PatentVest Releases New Pulse Report on the $19 Billion Amylin Drug Ra...

PatentVest Releases New Pulse Report on the $19 Billion Amylin Drug Race Transforming Obesity Treatment Dallas, TX, March 31, 2026 (GLOBE NEWSWIRE) -- PatentVest today released its latest PatentVest Pulse report, “The Amylin Renaissance: Forty Programs, $19 Billion in Deals, and the Race to Build the Next Pillar of Obesity Medicine.” The report provides a comprehensive analysis of the rapidly evolving amylin drug landscape, a mechanism once considered commercially unviable that is now at the center of global pharmaceutical strategy. Over the past eighteen months, more than $19 billion i...

 PRESS RELEASE

PatentVest Highlights New Legal Article on AI Patenting Strategy by Se...

PatentVest Highlights New Legal Article on AI Patenting Strategy by Senior Patent Attorney Sarah Cork Dallas, TX, March 30, 2026 (GLOBE NEWSWIRE) -- PatentVest today announced a new addition to its IP Legal Insights section on the company website, a platform dedicated to sharing expert legal perspectives on intellectual property strategy, emerging technology, and innovation-driven industries. The IP Legal Insights section serves as a resource for founders, executives, and investors seeking to better understand how intellectual property decisions impact innovation, competitive positioning...

 PRESS RELEASE

PatentVest Announces Life Seal Vascular Partnership, Takes Equity Stak...

PatentVest Announces Life Seal Vascular Partnership, Takes Equity Stake in Exchange for IP Intelligence Services IP Strategy and Legal firm backs vascular technology innovator with both expertise and capital commitment Dallas, TX, March 30, 2026 (GLOBE NEWSWIRE) -- PatentVest, a leading provider of IP Strategy and Legal services, today announced a strategic engagement with Life Seal Vascular and disclosed that it has accepted equity in the company as partial consideration for its services. The arrangement reflects PatentVest's conviction in Life Seal Vascular's underlying technology and...

 PRESS RELEASE

MDB Capital Holdings to Host Fourth Quarter and Full Year 2025 Results...

MDB Capital Holdings to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday, March 31, 2026 at 4:30 p.m. Eastern Time Addison, TX, March 23, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading disruptive technology companies, plans to host a Zoom webinar on Tuesday, March 31, 2026 at 4:30 p.m. Eastern Time to discuss its results for the fourth quarter and full year 2025. A press release detailing the results will be issued prior to the call. Christopher Marlett, CEO and Co-Founde...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch